Patient selection criteria and management guidelines for outpatient parenteral antibiotic therapy for native valve infective endocarditis

Clinical Infectious Diseases

Volumn 33, Issue 2, 2001, Pages 203-209

  Andrews, Mary Margaret ^a   Von Reyn, C Fordham ^a  

^a DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ANTIBIOTIC THERAPY; BACTERIAL ENDOCARDITIS; HUMAN; INFECTION COMPLICATION; OUTPATIENT CARE; PATIENT SELECTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; RISK FACTOR;

ANTI-BACTERIAL AGENTS; ENDOCARDITIS, BACTERIAL; HEALTH PLANNING GUIDELINES; HEART VALVES; HUMANS; OUTPATIENTS; PATIENT SELECTION; PRACTICE GUIDELINES;

EID: 0035879477     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/321814     Document Type: Review

References (83)

1. Management of complications of infective endocarditis
2. The prevention and treatment of bacterial endocarditis
3. Management of infective endocarditis
4. Endocarditis and intravascular infections
5. Drug therapy: Outpatient parenteral antimicrobial drug therapy
6. Infective endocarditis: Economic considerations
7. New approaches to the diagnosis and treatment of infective endocarditis: Review of 100 consecutive cases
8. Antibiotic treatment of adults with infective endocarditis due to Streptococci, Enterococci, Staphylococci, and HACEK microorganisms
9. Practice guidelines for community-based anti-infective therapy
10. Home intravenous antibiotic therapy: A safe and effective alternative to inpatient care
11. Feasibility of outpatient self-administration of parenteral antibiotics
12. Intravenous antibiotic therapy at home
13. Intravenous antibiotic therapy in an outpatient setting
14. Home intravenous antibiotic therapy: A team approach
15. Home treatment
16. Intravenous antibiotic therapy at home
17. Self-administration of intravenous antibiotics: An efficient, cost-effective home care program
18. Home intravenous antibiotic therapy
19. Outpatient parenteral antibiotic therapy. Management of serious infections. Part I: Medical, socioeconomic, and legal issues. Selecting the patient
20. Ceftriaxone and outpatient treatment of endocarditis
21. Outpatient parenteral antibiotic therapy. Management of serious infections. Part I: Medical, socioeconomic, and legal issues. The team concept
22. Outpatient treatment of endocarditis
23. Antibiotic management of outpatients with endocarditis due to penicillin-susceptible streptococci
24. Treatment of streptococcal endocarditis with a single daily dose of ceftriaxone sodium for 4 weeks
25. Treatment of streptococcal endocarditis with a single daily dose of ceftriaxone and netilmicin for 14 days: A prospective multicenter study
26. Ceftriaxone once daily for four weeks compared with ceftriaxone plus gentamicin once daily for two weeks for treatment of endocarditis due to penicillin-susceptible streptococci
27. Outpatient parenteral antibiotic therapy. Management of serious infections. Part II: Amenable infections and models for delivery. Endocarditis
28. Outpatient intravenous antibiotic therapy for endocarditis
29. Home antibiotic therapy for streptococcal endocarditis: A call for a controlled trial
30. Infective endocarditis at a large community teaching hospital, 1980-1990: A review of 210 episodes
31. Epidemiology of bacterial endocarditis in the Netherlands. I. Patient characteristics
32. Influence of referral bias on the apparent clinical spectrum on infective endocarditis
33. Staphylococcal endocarditis
34. Some factors affecting prognosis in bacterial endocarditis
35. Life-threatening complications of infective endocarditis and their management
36. Staphylococcal infective endocarditis
37. Valve ring abscess in active infective endocarditis: Frequency, location and clues to clinical diagnosis from the study of 95 necropsy patients
38. Heart failure in infective endocarditis: Predisposing factors, course, and treatment
39. Staphylococcus aureus endocarditis: Clinical manifestations in addicts and nonaddicts
40. Some salient features of Staphylococcus aureus endocarditis
41. Enterococcal endocarditis: A comparison of prosthetic and native valve disease
42. Infective endocarditis caused by β-hemolytic streptococci
43. Characteristics of left-sided endocarditis due to Pseudomonas aeruginosa in the Detroit Medical Center
44. Gram-negative bacterial endocarditis
45. Fungal endocarditis
46. Infective endocarditis
47. Infective endocarditis: Clinical features in young and elderly patients
48. Unfavourable prognostic factors in Staphylococcus aureus septicemia and endocarditis
49. Aortic insufficiency in bacterial endocarditis
50. Infective endocarditis - An evolving disease: A review of endocarditis at the Columbia-Presbyterian Medical Center, 1968-1973
51. Early identification of patients with native valve infectious endocarditis at risk for major complications by initial clinical presentation and baseline echocardiography
52. Valve site-specific pathogenetic differences between right-sided and left-sided bacterial endocarditis
53. Neurologic complications of bacterial endocarditis
54. Neurologic complications of endocarditis: A 12-year experience
55. Prognosis of native valve infective endocarditis: A review of 253 cases
56. The complications of infective endocarditis: A reappraisal in the 1980's
57. Duration of fever during treatment of infective endocarditis
58. Fever during treatment of infective endocarditis
59. Persistent fever in association with infective endocarditis
60. Response to therapy
61. Infective endocarditis in the antibiotic era
62. Prognostic significance of valvular regurgitation in patients with infective endocarditis
63. Relation between the presence of echocardiographic vegetations and the complication rate in infective endocarditis
64. Emboli in infective endocarditis: The prognostic value of echocardiography
65. Rate of cerebral embolic events in relation to antibiotic and anticoagulant therapy in patients with bacterial endocarditis
66. Echocardiography in infective endocarditis: Reassessment of prognostic implications of vegetation size determined by the transthoracic and transesophageal approach
67. Echocardiographic assessment of patients with infectious endocarditis: Prediction of risk for complications
68. Perivalvular extension of infections in patients with infectious endocarditis
69. Prosthetic valve endocarditis
70. Endocarditis-associated paravalvular abscesses: Do clinical parameters predict the presence of abscess?
71. Abscesses of the valve rings of the heart, a frequent but not well recognized complication of acute bacterial endocarditis
72. Myocardial abscess
73. Perivalvular abscesses associated with endocarditis. Clinical features and diagnostic accuracy of two-dimensional echocardiography
74. Predictive risk factors for periannular extension of native valve endocarditis. Clinical and echocardiographic analyses
75. Treatment of infective endocarditis: A 10-year comparative analysis
76. The relationship between new cardiac conduction defects and extension of valve infection in native valve endocarditis
77. Cardiac conduction abnormalities complicating native valve active infective endocarditis
78. Improvement in the diagnosis of abscesses associated with endocarditis by transesophageal echocardiography
79. Annular destruction
80. A critical appraisal of the quality of the management of infective endocarditis
81. Infective endocarditis: How well are we managing our patients?